Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces First Quarter 2014 Results and Operating Highlights Teleconference and Webcast

BETHESDA, Md., April 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), a global biopharmaceutical company, today announced that it will host a webcast and...
April 25, 2014 16:08 ET | Source: Sucampo Pharmaceuticals Inc

Preclinical Data for Lubiprostone and Unoprostone Isopropyl to be Presented at Experimental Biology Conference 2014

BETHESDA, Md., April 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that preclinical data for lubiprostone...
March 25, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to Receive Visionary Award From the Foundation Fighting Blindness

BETHESDA, Md., March 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the Foundation Fighting Blindness...
March 14, 2014 17:29 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(R) (lubiprostone)

BETHESDA, Md., March 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharma Americas, LLC, a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), and its development and...
March 12, 2014 20:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.

BETHESDA, Md., March 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) today announced that Sucampo Pharma Europe, Ltd., its wholly owned subsidiary, has received a...
March 05, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH Conference

BETHESDA, Md., March 5, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
March 04, 2014 10:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo and National Cherry Blossom Festival Announce Sucampo as Host and 'Step Into Spring' Program Sponsor for 2014

BETHESDA, Md. and WASHINGTON, March 4, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) and the National Cherry Blossom Festival (Festival) today announced their ongoing...
February 26, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results

Full Year Net Income Excluding Special Items of $9.4 Million, Up 94% over 2012 and Exceeds Guidance Company to Host Conference Call Today at 5:00 pm Eastern BETHESDA, Md., Feb. 26, 2014 (GLOBE...
February 12, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Fourth Quarter and Full Year 2013 Results and Operating Highlights Teleconference and Webcast

BETHESDA, Md., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), a global biopharmaceutical company, today announced that it will host a webcast and...
February 10, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Names Peter Greenleaf Chief Executive Officer

BETHESDA, Md., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced that Peter Greenleaf will join Sucampo as Chief Executive Officer ("CEO") and...